autovaccine production

what is an autovaccine?

autogenous vaccines: an inactivated immunological veterinary medicinal product that is manufactured from pathogens and antigens obtained from one or more animals in an epidemiological unit and used for the treatment of such animal(s) in the same epidemiological unit or for the treatment of one or more animals in a unit for which an epidemiological link has been confirmed.

Definition of autovaccine given in: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC.

specific: made from pathogenic strains obtained from the farm itself after identification and antigenic characterisation according to serotype, virulence factors or genetic sequencing; targeted to the farm itself or epidemiological unit

updated: constantly updated with the incorporation of recent strains according to new diagnoses

combinable: in multifactorial processes, it is necessary to include several pathogens in the same autovaccine

safe: they are inactivated, in no case can they reproduce the disease


what solutions can we offer you?



indicated when there is no registered veterinary vaccine for that animal species and that antigenic variant or existing vaccines have shown lack of efficacy

for the control by immunoprophylaxis of infectious processes present on farms

must be produced by an approved laboratory (REG Exopol No: 235/50/015-A)

are dispensed on veterinary prescription following confirmatory laboratory diagnosis



what steps do we follow for its production?


sampling

confirmation of the causative agent

order

manufacturing

quality control